Cargando…
The use of recombinant human growth hormone in patients with Mucopolysaccharidoses and growth hormone deficiency: a case series
BACKGROUND: The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant human growth hormone in this selected cohort...
Autores principales: | Cattoni, A., Motta, S., Masera, N., Gasperini, S., Rovelli, A., Parini, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676577/ https://www.ncbi.nlm.nih.gov/pubmed/31370860 http://dx.doi.org/10.1186/s13052-019-0691-1 |
Ejemplares similares
-
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
por: Hou, Ling, et al.
Publicado: (2015) -
An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency
por: XUE, YING, et al.
Publicado: (2016) -
Effect of Vitamin D Combined with Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency
por: Wang, Pingping, et al.
Publicado: (2022) -
Efficacy and Safety of Sustained-Release Recombinant Human Growth Hormone in Korean Adults with Growth Hormone Deficiency
por: Kim, Youngsook, et al.
Publicado: (2014) -
Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency
por: Gahlot, Monita, et al.
Publicado: (2019)